|6.42||-0.27 / -4.04%|
Data as of 3:59pm ET
|6.42||0.00 / 0.00%|
The 1 analysts offering 12-month price forecasts for Northwest Biotherapeutics Inc have a median target of 15.10, with a high estimate of 15.10 and a low estimate of 15.10. The median estimate represents a +135.20% increase from the last price of 6.42.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.